While jobs dropped 3.7% last year, the state is still home to the largest number of manufacturing-related life science jobs in the U.S., according to Biocom California.
The strategic realignment is aimed at better serving customers across the drug development lifecycle, from research and discovery to clinical and commercial manufacturing.
Smart manufacturing is “nearly universal” with 95% of manufacturers saying they are using or evaluating smart technology, according to a new survey from Rockwell Automation.
The CDMO completed site construction and infrastructure installation at its 50,000-square-foot facility, with full-scale GMP production slated for this summer.
U.S. Pharmacopeia CEO Ronald Piervincenzi told lawmakers that advanced manufacturing technologies will better enable production of pharmaceuticals and pharma ingredients.
Part of Danaher Corporation, Cytiva’s strategic investment in Asia-Pacific, Europe, and the United States aligns with its long-term growth plan to better serve customers.
The CDMO is expanding manufacturing sites in Lexington, Kentucky, and Riverview, Michigan, which are essential to its integrated antibody-drug conjugate offering.
The 25,000-square-meter site at Tuas Biomedical Park is slated to start operations by the end of 2025 and GMP manufacturing in early 2026, according to the company.
Unlock the full potential of your GMP assets. Discover how life sciences organizations can optimize reliability, compliance, and performance with a data-driven approach to Asset...
Three of Cognite's chemical, refining, and energy customers take center stage in this product tour video that showcases why and how they are transforming their operations.
Are you making quick-enough progress on your industrial Gen AI journey? Learn what it actually takes to trust, deliver, and scale across operational use cases.
Optimize safety, efficiency, and compliance in biopharma fluid handling with this essential guide to managing single-use bioprocess bags. Learn how modular, ergonomic, and contamination...
